Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 13, 2021 08:44 ET | Source: LexaGene Holdings Inc

LexaGene Initiates Program to Identify UK and South African COVID Sequences

BEVERLY, Mass., Jan. 13, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
January 06, 2021 07:58 ET | Source: LexaGene Holdings Inc

LexaGene to Present at Upcoming SNN Network and H.C. Wainwright Bioconnect 2021 Virtual Events

BEVERLY, Mass., Jan. 06, 2021 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
December 30, 2020 07:58 ET | Source: LexaGene Holdings Inc

LexaGene Starts FDA EUA Study for Point-of-Care COVID-19 Testing

BEVERLY, Mass., Dec. 30, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
December 17, 2020 07:58 ET | Source: LexaGene Holdings Inc

LexaGene to Place MiQLab Systems at Two Leading Specialty and Emergency Veterinary Care Hospitals

BEVERLY, Mass., Dec. 17, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
December 15, 2020 07:58 ET | Source: LexaGene Holdings Inc

LexaGene Receives Purchase Order for MiQLab from Ethos Discovery

BEVERLY, Mass., Dec. 15, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
December 09, 2020 07:58 ET | Source: LexaGene Holdings Inc

LexaGene to Participate at the 13th Annual LD Micro Main Event Conference

BEVERLY, Mass., Dec. 09, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
November 18, 2020 07:58 ET | Source: LexaGene Holdings Inc

LexaGene Places MiQLab System at the University of Pennsylvania’s School of Veterinary Medicine

BEVERLY, Mass., Nov. 18, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
November 16, 2020 07:58 ET | Source: LexaGene Holdings Inc

LexaGene Receives Purchase Order from a Multinational Biotechnology Company

BEVERLY, Mass., Nov. 16, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
November 13, 2020 17:00 ET | Source: LexaGene Holdings Inc

LexaGene Announces Results of Annual General Shareholder’s Meeting

BEVERLY, Mass., Nov. 13, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...
November 10, 2020 07:58 ET | Source: LexaGene Holdings Inc

LexaGene to Present at Two Upcoming Investor Conferences

BEVERLY, Mass, Nov. 10, 2020 (GLOBE NEWSWIRE) -- LexaGene Holdings, Inc., (TSX-V: LXG; OTCQB: LXXGF) (the “Company”), a molecular diagnostics company that develops fully automated rapid pathogen...

keyboard_arrow_left Previous Page

Next Page keyboard_arrow_right